Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Product/Service, Trade Show

ManageEngine Simplifies Cloud Cost Management for Enterprises Across Multi-Cloud Environments


ManageEngine, a division of Zoho Corp. and leading provider of enterprise IT management solutions, today announced that CloudSpend, its cloud cost management tool, has extended its support to Google Cloud Platform (GCP). By expanding its cost optimization services to GCP, following AWS and Microsoft Azure, CloudSpend now covers the three largest public cloud computing platforms worldwide by market share, enabling enterprises with a multi-cloud setup to streamline their operational expenses.

Furthermore, CloudSpend has been enhanced with a cost anomaly detection capability, which helps monitor and manage cost blind spots across multiple cloud service providers. The company will showcase CloudSpend's GCP features at Google Next 2024 on April 9 at booth #1660.

Multi-cloud is the way forward

Organizations are keen on embracing not just one but multiple cloud platforms to diversify their business operations, split workloads, ensure cost-cutting and eventually enjoy success. Consequentially, investments into public cloud adoption are expected to reach $679 billion in 2024, entailing an efficient cloud cost observability and optimization platform to maintain cloud finances.

"ManageEngine estimates that organizations operating in a multi-cloud environment often under-utilize their cloud resources, with their cloud usage topping at 55%. At ManageEngine, we believe that CloudSpend will help businesses rise above such challenges and advance in their cloud maturity journey by offering the visibility to stay on top of their investments. This multi-cloud cost intelligence platform follows FinOps best practices and is boosted with smart forecasting features that help reduce operational expenditure. It also bridges the gap between capacity planning and cost optimization for resources running in multi-cloud setups," said Srinivasa Raghavan, director of product management at ManageEngine.

Cost anomaly detection, the newest addition to CloudSpend's wide range of features, acts upon any cost-related anomalies at the organizational level. It identifies unexpected cost increases or resource usage that deviates significantly from the norm. It also provides insights on opaque pricing, where costs may be hidden and potentially higher than expected.

Other Key Features of ManageEngine CloudSpend

Pricing and Availability

The pricing model for CloudSpend caters to businesses of all sizes, offering free tracking of costs up to $3,000 per month of spending on GCP, AWS and Azure cloud. The paid version starts at 1% of monthly spend above $3,000 and is available to download on both iOS and Android. To learn more and sign up for a 30-day, free trial of CloudSpend, visit www.mnge.it/cdsd.

About ManageEngine

ManageEngine is a division of Zoho Corporation that offers comprehensive on-premises and cloud-native IT and security operations management solutions for global organizations and managed service providers. Established and emerging enterprises ? including nine of every 10 Fortune 100 organizations ? rely on ManageEngine's real-time IT management tools to ensure the optimal performance of their IT infrastructure, including networks, servers, applications, endpoints and more. ManageEngine has 18 data centers, 20 offices and 200+ channel partners worldwide to help organizations tightly align their business to IT. For more information, please visit the company site, follow the company blog and get connected on LinkedIn, Facebook, Instagram and X (formerly Twitter).


These press releases may also interest you

at 07:05
Cotiviti, a leading healthcare data analytics and technology business, announced today the close of its business recapitalization with two premier firms, affiliates of its long-standing partner Veritas Capital (Veritas) and investment funds managed...

at 07:05
Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca's CALQUENCE® (acalabrutinib) in combination with standard-of-care chemoimmunotherapy, bendamustine and rituximab, demonstrated a statistically...

at 07:05
IQVIA Holdings Inc. ("IQVIA") , a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024....

at 07:05
Franklin County School District today announced a exciting partnership with Varsity Tutors for Schools, a Nerdy company and the leading platform for live online tutoring, to provide all district students with access to the Varsity Tutors for Schools...

at 07:05
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today announced that the Company will release its...

at 07:05
Delphia Therapeutics, Inc. (Delphia), announced its launch today to pioneer a new area of cancer biology ? activation lethality ? which targets cancer's surprising vulnerability to oncogene overactivation. Leveraging this next-generation approach,...



News published on and distributed by: